Abstract
The characterisation of ivermectin pharmacokinetics can be used to predict and to ensure an optimal activity in the target species and for designing programmes aimed for parasite control. Ivermectin pharmacokinetic studies performed in several minor ruminant species are reviewed in this paper with the aim of facilitating the adoption of rational basis for the establishment of appropriate dosage schedules.
Keywords: Ivermectin, clinical use, minor ruminant species, pharmacokinetics
Current Pharmaceutical Biotechnology
Title:Extra-Label Use of Ivermectin in Some Minor Ruminant Species: Pharmacokinetic Aspects
Volume: 13 Issue: 6
Author(s): A. Gonzalez-Canga, R. Belmar-Liberato and M. Escribano
Affiliation:
Keywords: Ivermectin, clinical use, minor ruminant species, pharmacokinetics
Abstract: The characterisation of ivermectin pharmacokinetics can be used to predict and to ensure an optimal activity in the target species and for designing programmes aimed for parasite control. Ivermectin pharmacokinetic studies performed in several minor ruminant species are reviewed in this paper with the aim of facilitating the adoption of rational basis for the establishment of appropriate dosage schedules.
Export Options
About this article
Cite this article as:
Gonzalez-Canga A., Belmar-Liberato R. and Escribano M., Extra-Label Use of Ivermectin in Some Minor Ruminant Species: Pharmacokinetic Aspects, Current Pharmaceutical Biotechnology 2012; 13 (6) . https://dx.doi.org/10.2174/138920112800399112
DOI https://dx.doi.org/10.2174/138920112800399112 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Iron Deficiency: The Hidden Miscreant in Inflammatory Bowel Disease
Current Drug Targets Pharmacogenomics of Oral Antithrombotic Drugs
Current Pharmaceutical Design Translational Application of Combining Magnetic Resonance Imaging and Biomechanical Analysis in Carotid Plaque Vulnerability Assessment
Recent Patents on Medical Imaging The Clinical Spectrum of Nephrogenic Systemic Fibrosis
Current Rheumatology Reviews Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design Medication-Induced Acute Abdominal Pain: Evaluation with CT Imaging
Current Medical Imaging Colloid Update
Current Pharmaceutical Design Patents Review in siRNA Delivery for Pulmonary Disorders
Recent Patents on Drug Delivery & Formulation The Biochemical Mechanisms of T-Cell Anergy
Current Immunology Reviews (Discontinued) Pharmacological Treatment of Hypertension in Pregnancy
Current Pharmaceutical Design Autonomic Nervous System Alterations in Rett Syndrome
Current Pediatric Reviews Advances in Antithrombotic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacological Agents in the Treatment of Venous Disease: An Update of the Available Evidence
Current Vascular Pharmacology Pharmacodynamics and Pharmacokinetics of Antifungals for Treatment of Invasive Aspergillosis
Current Pharmaceutical Design Cardiovascular Effects of Modulators of Soluble Guanylyl Cyclase Activity
Cardiovascular & Hematological Agents in Medicinal Chemistry Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?
Current Vascular Pharmacology Changes in Markers of Bone Metabolism Following Surgery
Recent Patents on Biomarkers Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
Current Drug Targets - Cardiovascular & Hematological Disorders Hypercoagulability and Nephrotic Syndrome
Current Vascular Pharmacology Hypopituitarism in Neurocritical Patients: A Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets